Skip to main content
Equibles

Invesco Ltd.

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 914208 Atlanta, GA
Back to ZNTL Full portfolio

Position in ZNTL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$784,035
+$489,741 QoQ
Shares Held
161,657
+28.5% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 114 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 0% Shared 99% None 1%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. ZNTL ranks #164 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in ZNTL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $784,035 161,657
2026-03-31 $294,294 125,767
2025-12-31 $254,585 188,582
2025-09-30 $262,167 173,621
2025-06-30 $180,628 155,714
2025-03-31 $237,678 149,484
2024-12-31 $154,140 50,872
2024-09-30 $189,379 51,462
2024-06-30 $220,078 53,809
2024-03-31 $856,807 54,366
2023-12-31 $377,991 24,950
2023-09-30 $2,739,412 136,561
2023-06-30 $3,675,198 130,280
2023-03-31 $440,886 25,633
2022-12-31 $504,666 25,058
2022-09-30 $585,165 27,016
2022-06-30 $663,860 23,625
2022-03-31 $4,496,572 97,455
2021-12-31 $18,418,805 219,115
2021-09-30 $8,717,309 130,812
2021-06-30 $7,727,245 145,249
2021-03-31 $10,110,172 233,007
2020-12-31 $14,339,023 276,069
2020-09-30 $8,927,932 273,109
2020-06-30 $13,320,411 277,393